Rex Haydon to Transcription Factors
This is a "connection" page, showing publications Rex Haydon has written about Transcription Factors.
Connection Strength
0.061
-
Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine (Phila Pa 1976). 2003 Apr 15; 28(8):755-63.
Score: 0.028
-
Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res. 2002 May; 8(5):1288-94.
Score: 0.026
-
Fluorescence-based functional assay for Wnt/beta-catenin signaling activity. Biotechniques. 2002 Nov; 33(5):1126-8, 1130, 1132 passim.
Score: 0.007